Reuters logo
GW Pharma's cannabis drug helps in resistant epilepsy
June 17, 2014 / 11:10 AM / 3 years ago

GW Pharma's cannabis drug helps in resistant epilepsy

LONDON, June 17 (Reuters) - GW Pharmaceuticals, which is developing a range of drugs based on cannabis, said on Tuesday its experimental product Epidiolex had produced promising results in children and young adults with treatment-resistant epilepsy.

The findings follow an assessment of 27 patients treated with the drug for 12 weeks.

Reporting by Ben Hirschler; editing by Kate Kelland

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below